152 related articles for article (PubMed ID: 7875170)
1. Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma.
Kirsch CM; von Pawel J; Grau I; Tatsch K
Eur J Nucl Med; 1994 Dec; 21(12):1318-25. PubMed ID: 7875170
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma].
Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW
Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059
[TBL] [Abstract][Full Text] [Related]
3. The value of octreotide scintigraphy in patients with lung cancer.
Kwekkeboom DJ; Kho GS; Lamberts SW; Reubi JC; Laissue JA; Krenning EP
Eur J Nucl Med; 1994 Oct; 21(10):1106-13. PubMed ID: 7828621
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study.
Reisinger I; Bohuslavitzki KH; Brenner W; Braune S; Dittrich I; Geide A; Kettner B; Otto HJ; Schmidt S; Munz DL
J Nucl Med; 1998 Feb; 39(2):224-7. PubMed ID: 9476922
[TBL] [Abstract][Full Text] [Related]
5. Octreotide scintigraphy for small cell lung carcinoma: past, present or future?
Stokkel MP; Pauwels EK
Eur J Nucl Med; 1994 Dec; 21(12):1276-8. PubMed ID: 7875163
[No Abstract] [Full Text] [Related]
6. Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.
Bombardieri E; Crippa F; Cataldo I; Chiti A; Seregni E; Soresi E; Boffi R; Invernizzi G; Buraggi GL
Eur J Cancer; 1995; 31A(2):184-8. PubMed ID: 7718323
[TBL] [Abstract][Full Text] [Related]
7. Factor analysis of dynamic series (FADS) in somatostatin receptor imaging.
Kolesnikov-Gauthier H; Huglo D; Nocaudie M; Marchandise X
J Nucl Med; 1999 Jan; 40(1):33-9. PubMed ID: 9935053
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.
O'Byrne KJ; Ennis JT; Freyne PJ; Clancy LJ; Prichard JS; Carney DN
Br J Cancer; 1994 Apr; 69(4):762-6. PubMed ID: 7908220
[TBL] [Abstract][Full Text] [Related]
9. Imaging of non-small-cell lung cancer with indium-111 pentetreotide.
Lau SK; Johnson DS; Coel MN
Clin Nucl Med; 2000 Jan; 25(1):24-8. PubMed ID: 10634526
[TBL] [Abstract][Full Text] [Related]
10. [Ultrasound tumor staging of bronchial cancer].
Schulz G; Nürnberg D
Z Arztl Fortbild (Jena); 1992 May; 86(9):445-9. PubMed ID: 1318620
[No Abstract] [Full Text] [Related]
11. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers.
Atasever T; Gündoğdu C; Vural G; Kapucu LO; Karalezli A; Unlü M
Nuklearmedizin; 1997 Oct; 36(7):223-7. PubMed ID: 9394361
[TBL] [Abstract][Full Text] [Related]
12. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
Lee HY; Chung JK; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
Ann Nucl Med; 2008 May; 22(4):281-6. PubMed ID: 18535878
[TBL] [Abstract][Full Text] [Related]
13. [Computed tomography in brain metastases of bronchogenic carcinoma].
Liu ZX
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Jun; 11(3):139-41, 190. PubMed ID: 2851390
[No Abstract] [Full Text] [Related]
14. Somatostatin receptor expression in lung cancer.
O'Byrne KJ; Halmos G; Pinski J; Groot K; Szepeshazi K; Schally AV; Carney DN
Eur J Cancer; 1994; 30A(11):1682-7. PubMed ID: 7833144
[TBL] [Abstract][Full Text] [Related]
15. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules.
Blum JE; Handmaker H; Rinne NA
Chest; 1999 Jan; 115(1):224-32. PubMed ID: 9925088
[TBL] [Abstract][Full Text] [Related]
16. Contribution of (99m)Tc-depreotide (Neospect) scintigraphy in lung cancer staging.
Karathanos E; Datseris I; Vlontzou E; Zisimopoulos A; Georgiou E
J BUON; 2010; 15(1):147-52. PubMed ID: 20414943
[TBL] [Abstract][Full Text] [Related]
17. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
Bombardieri E; Chiti A; Crippa F; Seregni E; Cataldo I; Maffioli L; Soresi E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):104-7. PubMed ID: 9002763
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor scintigraphy in the staging of small cell lung cancer.
Bohuslavizki KH; Brenner W; Günther M; Eberhardt JU; Jahn N; Tinnemeyer S; Wolf H; Sippel C; Clausen M; Gatzemeier U; Henze E
Nucl Med Commun; 1996 Mar; 17(3):191-6. PubMed ID: 8692484
[TBL] [Abstract][Full Text] [Related]
20. The use of radiolabeled somatostatin analog scintigraphy in the staging of small cell lung cancer patients.
Tzannou IA; Karapanagiotou EM; Charpidou A; Dilana K; Alamara C; Christakopoulou I; Georgiou E; Syrigos KN
Am J Clin Oncol; 2007 Oct; 30(5):503-6. PubMed ID: 17921711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]